Extracellular vesicles (EVs) are small lipid bilayer structures released from different cell types and contain bioactive molecules including nucleic acids and proteins that shape the tumor microenvironment through cell-cell interaction. Tumor-derived EVs have been demonstrated to play a critical role in promoting an immunosuppressive landscape that ultimately contributes to immune escape. In glioblastoma, we found that tumor-derived EVs induced the expansion of myeloid-derived suppressor cells (MDSCs), which impair T cell proliferation in vitro. The mechanisms of EV uptake including lipid-raft mediated endocytosis have been well described. These cholesterol rich microdomains on cellular membranes act as a docking mechanism for EV uptake. Co-culturing of GBM-derived EVs with donor monocytes in the presence of Methylβ-cyclodextrin, a cholesterol depleting reagent, resulted in impaired EV uptake by monocytes, reversal of MDSC induction, and rescue of T cell proliferation in a dose-dependent manner. These results serve as a possible avenue for finding treatment adjuncts along with immune checkpoint inhibitors to combat the immunosuppressive milieu in glioblastoma.
Inhibition of lipid raft-mediated endocytosis prevents the induction of MDSCs by glioblastoma extracellular vesicles.
Category
Late Breaking Abstracts
Description
Custom CSS
double-click to edit, do not edit in source
Date: May 6 Presentation Time: 11:30 AM to 12:45 PM Room: Exhibit Hall F1